Skip to content

Clinical Outcome in Uveitis

Clinical Outcome and Causes of Visual Loss in Uveitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01983488
Enrollment
231
Registered
2013-11-14
Start date
2011-09-30
Completion date
2019-12-01
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uveitis

Keywords

Uveitis, Vision Loss

Brief summary

This study is aimed at investigating the long term clinical outcome of patients with uveitis.

Detailed description

Patients will be included if they are treated for uveitis and have had repeat follow-up. Data will be gathered from the entire length of the patients follow-up. The main outcome measures will be: Change from baseline of Best corrected visual acuity (BCVA)at 10 years Causes of vision loss (≤6/15, VL) and severe vision loss (≤6/60, SVL) at 10 years Number of clinical visits at 10 years.

Interventions

None listed

Sponsors

Moorfields Eye Hospital NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Clinical Diagnosis of Uveitis.

Exclusion criteria

* No follow-up data.

Design outcomes

Primary

MeasureTime frameDescription
Best Corrected Visual Acuityup to 10 yearsRecorded repeat best corrected visual acuity at intervals throughout the length of follow-up.

Secondary

MeasureTime frameDescription
Causes of visual lossFirst follow-up, years 1,2,5,10, Final follow-upRecord any ocular changes related to permanent visual loss under 6/12 and severe visual loss under 6/60.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026